Companies: 10,795·Total market cap: $144.5T
ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLNNASDAQHealthcare
$0.60
$-0.10(-14.27%)
Market Cap$777122375
P/E Ratio
52W High$17.04
52W Low$0.475

ASLAN Pharmaceuticals Limited(ASLN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ASLN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-122022-122021-122020-122019-12
Revenue
Revenue$12.00M$0.00M$0.00M$0.00M$3.00M
Cost of Revenue$0.35M$0.33M$0.28M$0.30M$0.41M
Gross Profit$11.65M($0.33M)($0.28M)($0.30M)$2.59M
Gross Margin %(computed)97.10%86.42%
Operating Expenses
R&D Expenses$42.50M$38.00M$22.02M$9.31M$16.59M
G&A Expenses$13.24M$9.88M$11.83M$7.17M$8.51M
Total Operating Expenses$55.39M$47.88M$33.85M$16.48M$48.17M
Operating Income($43.74M)($47.88M)($33.85M)($16.48M)($45.58M)
Operating Margin %(computed)-364.46%
Interest Income$0.40M$0.35M$0.00M$0.00M$0.15M
Interest Expense$4.33M$3.68M$1.86M$1.25M$0.90M
Income Before Tax($44.09M)($51.28M)($31.59M)($16.97M)($46.66M)
Income Tax Expense$0.13M$0.10M$3.12M$0.93M$0.41M
Net Income($44.22M)($51.38M)($34.71M)($17.91M)($47.07M)
Net Margin %(computed)-368.50%
Per Share & EBITDA
EPS (Basic)$-10.76$-14.72$-10.64$-9.32$-29.00
Wtd Avg Shares4.11M3.49M3.26M1.92M1.62M
EBITDA($39.40M)($47.28M)($29.45M)($15.43M)($45.31M)
EBITDA Margin %(computed)-328.36%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解ASLAN Pharmaceuticals Limited

关于ASLAN Pharmaceuticals Limited(ASLN)损益表

ASLAN Pharmaceuticals Limited(ASLN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,ASLN实现营收$0.01B,毛利润$0.01B(毛利率97.10%),净利润($0.04B)(净利率-368.50%)。

常见问题

ASLN · 4 问

ASLAN Pharmaceuticals Limited(ASLN)2023财年营收为$0.01B,同比up—%。

ASLN revenueASLN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09